Milae Bioresources
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Milae Bioresources makes specialty feed ingredients and additives used in compound animal feed, the mixed-grain rations that livestock farmers feed to cattle, pigs, and poultry.
Its products include specially heat-processed raw materials designed to remove anti-nutritional factors and boost nutrient absorption, functional ingredients that enhance specific biological effects, and premix additives that combine multiple functional substances in custom ratios. The company also supplies products for the pet health-food market. It is listed on KOSDAQ, South Korea's tech and small-cap exchange.
Summary is AI-generated and may contain errors · figures from DART filings
Milae Bioresources in five facts
What does Milae Bioresources do?
Milae Bioresources makes specialty feed ingredients and additives used in compound animal feed, the mixed-grain rations that livestock farmers feed to cattle, pigs, and poultry.
Where is Milae Bioresources listed and in which sector?
Milae Bioresources (Korean name: 미래생명자원) trades under KRX code 218150 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Consumer Staples sector, Food & Beverage.
How large is Milae Bioresources?
Its market capitalisation was US$28.2M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Milae Bioresources's latest annual revenue and operating profit?
For fiscal year 2025, Milae Bioresources reported revenue of US$51M, an operating loss of US$1.1M and a net loss of US$2.3M, per its annual report on DART (data retrieved from DART on 2026-09-18). Revenue was up 8.2% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-18
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- [Amended] Material event report (equity acquisition)M&A · Jun 26
- Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Milae Bioresources reported consolidated results for FY2025: revenue of US$46.8M (+8.17% year on year), an operating loss of US$1M (from a profit a year earlier) and a net loss of US$2.17M.
Earnings · Feb 24